Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
naltrexone (revia) (1 trial)
triamcinolone (kenalog) (1 trial)
Bursitis (Phase 3)
Opioid-Related Disorders (Phase 3)
Periarthritis (Phase 3)
Recurrence (Phase 3)
Trials (2 total)
Trial APIs (2 total)